| Trial name or title | The Cameroon mobile phone SMS (CAMPS) trial: A randomized controlled trial of mobile phone text messaging versus usual care for improving adherence to highly active anti‐retroviral therapy. |
| Methods | Single‐centered randomized controlled single‐blinded trial |
| Participants | Subjects who are aged above 21 years, own a mobile phone and can read text messages, and who have been on HAART for at least a month. N=198 |
| Interventions | A short weekly text message to the participants in the intervention group in both French and English. The content of the message will be motivating and will act both as a reminder and a cue to action. The message will also contain a phone number they can call back if they need help. |
| Outcomes | Adherence. Secondary endpoints will be; • Clinical: Weight, BMI, opportunistic infections • Biological: CD4 count, viral load • Quality of life (QOL): Measured with the SF‐12 QOL assessment form • All cause mortality • Retention |
| Starting date | 2010 |
| Contact information | Lawrence Mbuagbaw: mbuagbawl@yahoo.com |
| Notes | http://clinicaltrials.gov/NCT01247181 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.